Comparison 3. Tacrolimus versus beclometasone.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
3.1 Achievement of clinical remission | 1 | 88 | Risk Ratio (M‐H, Random, 95% CI) | 1.07 [0.60, 1.88] |
3.2 Clinical improvement | 1 | 88 | Risk Ratio (M‐H, Random, 95% CI) | 1.00 [0.66, 1.52] |
3.3 Serious adverse events | 1 | 88 | Risk Ratio (M‐H, Random, 95% CI) | 3.00 [0.13, 71.70] |
3.4 Total adverse events | 1 | 88 | Risk Ratio (M‐H, Random, 95% CI) | 1.50 [0.88, 2.55] |